Walleye Trading’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-502
Closed -$35.1K 5816
2022
Q2
$40K Buy
+502
New +$47.5K ﹤0.01% 4395
2022
Q1
Sell
-14,885
Closed -$1.45M 6230
2021
Q4
$1.6M Buy
14,885
+10,668
+253% +$1.16M 0.01% 1832
2021
Q3
$462K Buy
4,217
+4,094
+3,328% +$425K ﹤0.01% 2997
2021
Q2
$12K Sell
123
-63,617
-100% -$5.85M ﹤0.01% 4939
2021
Q1
$5.87M Buy
63,740
+42,475
+200% +$3.58M 0.03% 554
2020
Q4
$1.56M Buy
+21,265
New +$1.58M 0.01% 1602
2020
Q1
Sell
-5,358
Closed -$181K 4929
2019
Q4
$194K Buy
+5,358
New +$164K ﹤0.01% 3190
2019
Q2
Sell
-13,953
Closed -$354K 4791
2019
Q1
$369K Buy
+13,953
New +$331K ﹤0.01% 2520
2018
Q3
Sell
-23,411
Closed -$445K 5719
2018
Q2
$388K Buy
23,411
+22,497
+2,461% +$343K ﹤0.01% 3072
2018
Q1
$13K Sell
914
-16,501
-95% -$244K ﹤0.01% 4339
2017
Q4
$254K Buy
+17,415
New +$245K ﹤0.01% 3252
2017
Q3
Sell
-9,150
Closed -$116K 4837
2017
Q2
$109K Sell
9,150
-1,938
-17% -$24.1K ﹤0.01% 3504
2017
Q1
$164K Sell
11,088
-11,000
-50% -$178K ﹤0.01% 3100
2016
Q4
$357K Sell
22,088
-1,003
-4% -$18.2K ﹤0.01% 2363
2016
Q3
$419K Buy
23,091
+6,500
+39% +$127K ﹤0.01% 2270
2016
Q2
$273K Buy
16,591
+11,354
+217% +$184K ﹤0.01% 2718
2016
Q1
$87K Buy
+5,237
New +$91.6K ﹤0.01% 3459
2015
Q3
Sell
-4,551
Closed -$144K 5761
2015
Q2
$158K Buy
+4,551
New +$139K ﹤0.01% 2670

Other funds holding HZNP

Walleye Trading's HZNP Position: Q3 2022 in Review

Walleye Trading sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2022, closing a stake of 502 shares — an estimated $35.1K sold.

Walleye Trading first reported a position in HZNP in Q2 2015 and held it in 18 quarters. The position peaked at $5.87M in Q1 2021. 529 funds tracked by Wall St. Rank hold HZNP as of Q3 2022.

  • Walleye Trading reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2022 after selling out during the quarter.
  • Walleye Trading sold 502 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2022, an estimated $35.1K.
  • Walleye Trading first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2015 and held it in 18 quarters.
  • Walleye Trading's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $5.87M in Q1 2021.
  • 529 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2022.

Based on Walleye Trading's 13F filing for Q3 2022, filed 14 Nov 2022.